LKT Labs, 849217-68-1, Biologically Active Small Molecules

Sort
View
Show
  • LKT Labs

    Cabozantanib is an anticancer chemotherapeutic compound that has been approved to treat medullary thyroid cancer and is in clinical trials as a treatment for other types of solid tumors. Cabozantanib exerts its anticancer activity through inhibition of Met, RET, and VEGFR2, increasing apoptosis and…